Collectively, our data indicate that RASSF9 plays a key role in tumorigenesis of NSCLC by stimulating tumor cell proliferation, which relies on activation of the MEK/ERK axis. The gene discussed is MAP2K7; the disease is non-small cell lung carcinoma.